INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Albert Benjamin reported HCAT

Director, CEO · Health Catalyst, Inc. · Common Stock

Side
A
Value
—
Shares
1,124
Price
—
Executed
Apr 29, 2026
Disclosed
May 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 29 executedMay 1, 2026 disclosed

HCAT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · 0.1% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HCAT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$59K
    35.2K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$547
    321 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    18
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$58K
    34.5K sh
    		Jun 10, 2026Jun 15, 2026
    traded Jun 10, 2026
    		+5dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$460
    336 sh
    		Jun 1, 2026Jun 3, 2026
    traded Jun 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$417
    310 sh
    		May 1, 2026May 1, 2026
    traded May 1, 2026
    		+0dSEC FORM 4

    Evidence

    22
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$130K
    70.5K sh
    		Mar 10, 2026Mar 13, 2026
    traded Mar 10, 2026
    		+3dSEC FORM 4

    Evidence

    15
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$8,243
    4,966 sh
    		Mar 2, 2026Mar 5, 2026
    traded Mar 2, 2026
    		+3dSEC FORM 4

    Evidence

    15
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$35K
    20.8K sh
    		Mar 2, 2026Mar 5, 2026
    traded Mar 2, 2026
    		+3dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    38.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    5
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    16.5K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    5
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$11K
    6,317 sh
    		Feb 26, 2026Feb 27, 2026
    traded Feb 26, 2026
    		+1dSEC FORM 4

    Evidence

    21
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    930.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$23K
    13.3K sh
    		Feb 26, 2026Feb 27, 2026
    traded Feb 26, 2026
    		+1dSEC FORM 4

    Evidence

    17
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    289.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    43
    LJ
    Larson-Green JulieDirector
    HCATHealth Catalyst, Inc.
    Open-market sale
    		SELL$128K
    48.0K sh
    		Dec 4, 2025Dec 9, 2025
    traded Dec 4, 2025
    		+5dSEC FORM 4

    Evidence

    21
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$72K
    27.4K sh
    		Dec 5, 2025Dec 9, 2025
    traded Dec 5, 2025
    		+4dSEC FORM 4

    Evidence

    13
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$42K
    14.4K sh
    		Dec 1, 2025Dec 3, 2025
    traded Dec 1, 2025
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002086403-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 29, 2026
    Published
    May 1, 2026
    Ingested by INSIDER
    Nov 5, 04:01 UTC
    Last re-read
    Nov 5, 04:01 UTC

    Extracted facts

    Filer
    Albert Benjamin
    Role
    Director, CEO
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Health Catalyst, Inc.
    Ticker
    HCAT
    Shares
    1,124
    Price per share
    $0
    Execution date (reported)
    Apr 29, 2026
    Owned after transaction
    1.46M shares
    Days from execution to publication
    2

    What this establishes

    Albert Benjamin filed this Form 4 reporting a grant or award of HCAT on Apr 29, 2026. It became public on May 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, CEO
    Albert Benjamincik:0002086403
    Issuer
    Health Catalyst, Inc.cik:0001636422

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.